|
Market Closed -
NYSE
21:00:00 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.800 USD | -1.41% |
|
+5.26% | +55.56% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.83x | - | -0.03x | - | - | - | - | 229M | |
| 33.27x | 21.15x | 0.62x | 12.06x | 24.51x | 25.94x | 0.59% | 1,043B | |
| 29.94x | - | -1.62x | 6.66x | 18.64x | 20.95x | 2% | 649B | |
| 33.54x | -482.96x | 0.14x | 7.85x | 16.21x | 16.9x | 2.59% | 469B | |
| 19.72x | 7.24x | 1.31x | 4.82x | 11.95x | 13.27x | 2.75% | 355B | |
| 20.01x | 5.69x | -11.55x | 5.21x | 12.94x | 13.81x | 3.07% | 270B | |
| 21.55x | 4.86x | 1.08x | 4.46x | 12.7x | 13.37x | 1.98% | 262B | |
| 26.04x | 19.6x | 2.43x | 6.76x | 12.04x | 15.52x | 2.46% | 222B | |
| -46.18x | 11.37x | 0.31x | 6.71x | 26.22x | 63.61x | 2.16% | 189B | |
| 11.59x | 4.89x | -3.86x | 4.21x | 8.76x | 10.25x | 4.34% | 175B | |
| 17.61x | 1.81x | 1.06x | 3.32x | 8.5x | 9.67x | 6.16% | 159B | |
| 52.93x | 8.36x | -1.45x | 9.53x | 32.67x | 26.23x | -.--% | 131B | |
| 11.09x | 5.23x | 0.18x | 3.13x | 8.14x | 8.76x | 4.06% | 127B | |
| 11.85x | 1.2x | -6.27x | 2.11x | 6.83x | 7.56x | 5.72% | 102B | |
| 14.63x | 4.66x | -1.91x | 2.86x | 8.46x | 9.41x | 3.65% | 102B | |
| 21.93x | 4.94x | 1.32x | 7.34x | 13.93x | 14.62x | 2.02% | 70.52B | |
| 47.25x | 1.28x | 13.41x | 2.86x | 10.47x | 28.58x | 3.42% | 60.55B | |
| 22.42x | 1.73x | -0.14x | 1.72x | 8.11x | 13.94x | 0.32% | 55.7B | |
| 32.84x | 4.43x | 1.82x | 7.69x | 26.04x | 29.13x | 0.53% | 44.97B | |
| Average | 20.73x | -22.03x | -0.17x | 5.52x | 14.84x | 18.97x | 2.66% | 236.09B | |
| Weighted average by Cap. | 24.05x | -49.05x | -0.59x | 7.17x | 17.15x | 20.16x | 2.23% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
